ArticleHuman cell2021

STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells.

Qian Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.